These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 2415719)

  • 1. Passive immune protection by herpes simplex virus-specific monoclonal antibodies and monoclonal antibody-resistant mutants altered in pathogenicity.
    Kümel G; Kaerner HC; Levine M; Schröder CH; Glorioso JC
    J Virol; 1985 Dec; 56(3):930-7. PubMed ID: 2415719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic variants of herpes simplex virus selected with glycoprotein-specific monoclonal antibodies.
    Holland TC; Marlin SD; Levine M; Glorioso J
    J Virol; 1983 Feb; 45(2):672-82. PubMed ID: 6187935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies to the distinct antigenic sites on glycoproteins C and B and their protective abilities in herpes simplex virus infection.
    Bystrická M; Petríková M; Zatovicová M; Soláriková L; Kostolanský F; Mucha V; Russ G
    Acta Virol; 1997 Feb; 41(1):5-12. PubMed ID: 9199708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helper T cells induced by an immunopurified herpes simplex virus type I (HSV-I) 115 kilodalton glycoprotein (gB) protect mice against HSV-I infection.
    Chan WL; Lukig ML; Liew FY
    J Exp Med; 1985 Oct; 162(4):1304-18. PubMed ID: 2995536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of herpes simplex virus glycoproteins B and C using monoclonal antibodies and their ability to protect mice against lethal challenge.
    Roberts PL; Duncan BE; Raybould TJ; Watson DH
    J Gen Virol; 1985 May; 66 ( Pt 5)():1073-85. PubMed ID: 2582080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2.
    Balachandran N; Bacchetti S; Rawls WE
    Infect Immun; 1982 Sep; 37(3):1132-7. PubMed ID: 6290390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic variation (mar mutations) in herpes simplex virus glycoprotein B can induce temperature-dependent alterations in gB processing and virus production.
    Marlin SD; Highlander SL; Holland TC; Levine M; Glorioso JC
    J Virol; 1986 Jul; 59(1):142-53. PubMed ID: 2423702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against zosteriform spread of herpes simplex virus by monoclonal antibodies.
    Mester JC; Glorioso JC; Rouse BT
    J Infect Dis; 1991 Feb; 163(2):263-9. PubMed ID: 1846388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of herpes simplex virus glycoproteins gC and gB and their role in protective immunity.
    Glorioso J; Schröder CH; Kumel G; Szczesiul M; Levine M
    J Virol; 1984 Jun; 50(3):805-12. PubMed ID: 6328010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration.
    Highlander SL; Sutherland SL; Gage PJ; Johnson DC; Levine M; Glorioso JC
    J Virol; 1987 Nov; 61(11):3356-64. PubMed ID: 2444713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of herpes simplex virus type 1 (HSV-1) glycoprotein gC as the immunodominant antigen for HSV-1-specific memory cytotoxic T lymphocytes.
    Glorioso J; Kees U; Kümel G; Kirchner H; Krammer PH
    J Immunol; 1985 Jul; 135(1):575-82. PubMed ID: 2582051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease.
    Dix RD; Pereira L; Baringer JR
    Infect Immun; 1981 Oct; 34(1):192-9. PubMed ID: 6271681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of glycosylation of herpes simplex virus glycoproteins: identification of antigenic and immunogenic partially glycosylated glycopeptides on the cell surface membrane.
    Glorioso J; Szczesiul MS; Marlin SD; Levine M
    Virology; 1983 Apr; 126(1):1-18. PubMed ID: 6189286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissection of the antibody response against herpes simplex virus glycoproteins in naturally infected humans.
    Cairns TM; Huang ZY; Whitbeck JC; Ponce de Leon M; Lou H; Wald A; Krummenacher C; Eisenberg RJ; Cohen GH
    J Virol; 2014 Nov; 88(21):12612-22. PubMed ID: 25142599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycoprotein gB of herpes simplex virus expresses type-common and type-specific antigenic determinants in vivo.
    Dix RD
    J Med Virol; 1990 Mar; 30(3):192-5. PubMed ID: 1692872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epitopes of herpes simplex virus type 1 glycoprotein gC are clustered in two distinct antigenic sites.
    Marlin SD; Holland TC; Levine M; Glorioso JC
    J Virol; 1985 Jan; 53(1):128-36. PubMed ID: 2578193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different mechanisms of protection by monoclonal and polyclonal antibodies during the course of herpes simplex virus infection.
    Eis-Hübinger AM; Mohr K; Schneweis KE
    Intervirology; 1991; 32(6):351-60. PubMed ID: 1657825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of the biological properties of monoclonal antibodies against glycoprotein D of herpes simplex virus and identification of amino acid substitutions that confer resistance to neutralization.
    Minson AC; Hodgman TC; Digard P; Hancock DC; Bell SE; Buckmaster EA
    J Gen Virol; 1986 Jun; 67 ( Pt 6)():1001-13. PubMed ID: 2423636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex virus type 1-specific immunity induced by peptides corresponding to an antigenic site of glycoprotein B.
    Mester JC; Highlander SL; Osmand AP; Glorioso JC; Rouse BT
    J Virol; 1990 Nov; 64(11):5277-83. PubMed ID: 1698994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.